Initial Sulfonylurea Use and Subsequent Insulin Therapy in Older Subjects with Type 2 Diabetes Mellitus
Authors:
Open Access
- 18 October 2012
- journal article
- research article
- Published by Springer Nature in Diabetes Therapy
- Vol. 3 (1) , 1-9
Abstract
In type 2 diabetes mellitus (T2DM), progressive loss of beta cell function over time requires treatment intensification and eventually initiation of insulin for many patients. Relative to metformin, a greater rate of decline in beta cell function over time has been observed with sulfonylurea treatment. The present study examined the association between initial monotherapy with metformin or sulfonylurea and subsequent initiation of insulin in older subjects with T2DM.Keywords
This publication has 25 references indexed in Scilit:
- Factors associated with initiation of antihyperglycaemic medication in UK patients with newly diagnosed type 2 diabetesBMC Endocrine Disorders, 2012
- Pancreatic Function, Type 2 Diabetes, and Metabolism in AgingInternational Journal of Endocrinology, 2012
- Time to treatment initiation with oral antihyperglycaemic therapy in US patients with newly diagnosed type 2 diabetesDiabetes, Obesity and Metabolism, 2011
- Effects of Rosiglitazone, Glyburide, and Metformin on β-Cell Function and Insulin Sensitivity in ADOPTDiabetes, 2011
- Time to insulin treatment and factors associated with insulin prescription in Swedish patients with type 2 diabetesDiabetes & Metabolism, 2010
- Initiation of insulin therapy in elderly patients taking oral antidiabetes drugsCanadian Medical Association Journal, 2009
- Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary careDiabetic Medicine, 2007
- Glycemic Durability of Rosiglitazone, Metformin, or Glyburide MonotherapyNew England Journal of Medicine, 2006
- Addressing the issue of channeling bias in observational studies with propensity scores analysisResearch in Social and Administrative Pharmacy, 2006
- The central role of the propensity score in observational studies for causal effectsBiometrika, 1983